Veracyte | VCYT - Ebitda


Veracyte reported $43.96M in EBITDA for its fiscal quarter ending in June of 2026.





Ebitda Change Date
Agenus USD -10.11M 19.02M Mar/2025
Agilent USD 456M 84M Dec/2025
Anika Therapeutics USD 4.54M 3.67M Dec/2025
Arrowhead Research USD -107.35M 164.52M Mar/2026
Bruker USD 143.2M 33.2M Jun/2026
Heron Therapeutics USD -3.88M 5.63M Sep/2024
Illumina USD 330M 80M Jun/2026
Intrexon USD -24.7M 2.92M Jun/2024
Karyopharm Therapeutics USD -26.2M 1.83M Sep/2024
Laboratory Of America USD 767.7M 162.1M Jun/2026
Ligand Pharmaceuticals USD -14.3M 81.08M Mar/2026
Myriad Genetics USD 14.3M 4M Dec/2025
Rigel Pharmaceuticals USD -4.17M 798K Sep/2023
Roche Holding CHF 13.43B 744M Jun/2026
Siemens EUR 4.2B 644M Jun/2026
Sonic Healthcare AUD 839.07M 51.09M Dec/2024
Thermo Fisher Scientific USD 3.55B 845M Jun/2026
Veracyte USD 43.96M 1.16M Jun/2026
Waters USD 712M 545M Jun/2026